Across the recent three months, 5 analysts have shared their insights on Dianthus Therapeutics DNTH, expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...
Dianthus Therapeutics (NASDAQ:DNTH) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback